People

Emily Jane Cook

Partner

Los Angeles

Washington, DC

Areas of focus

Advises healthcare providers, from startups to established market leaders, on complex federal and state regulatory and reimbursement matters

Serves as a national authority on the 340B Drug Pricing Program

Counsels clients on fraud and abuse laws, Medicare provider-based and co-location rules, pharmacy laws and licensure, graduate medical education, rural providers, and federally qualified health centers

Advises on the development of innovative healthcare delivery models

Emily Jane Cook serves as counsel to clients in the healthcare sector, ranging from startups to established market leaders, on a wide range of critical regulatory and reimbursement matters to ensure compliant business operations. Her guidance allows these organizations to manage the risks associated with operating in a high-complexity and highly regulated sector.

See more

“Emily is a powerhouse in healthcare regulatory law with deep expertise and the ability to quickly identify and address issues across various regulatory domains.”

Chambers USA

Ranked in

Ranked in

Chambers USA, Healthcare

Ranked in

Ranked in

The Best Lawyers in America, Healthcare Law

Recognized by

Recognized by

Thomson Reuters, Stand-Out Lawyer – independently rated lawyers

Results
  • Obtained favorable outcomes for clients in False Claims Act whistleblower actions, government investigations, regulatory appeals, and self-disclosures to federal and state regulatory agencies, preserving government program participation and avoiding administrative penalties
  • Represented clients in landmark litigation that overturned long-standing 340B Program policies that limited opportunities for 340B providers to fully realize the congressional intent of the 340B Program
  • Counseled many large national health systems and academic medical centers through the development and implementation of innovative care models, including collaborative care models across facilities and between different types of clinical professionals, intended to maximize care quality and efficiency while maintaining regulatory compliance
  • Advised many 340B providers on the implementation of 340B Program operational and care delivery models to compliantly expand 340B Program revenue and opportunities to grow healthcare offerings in their communities
  • Successfully appealed adverse findings in government audits of 340B Programs for multiple hospital clients and negotiated corrective action plans, enabling the hospitals to continue leveraging program participation for their patients and communities

See more

Recognitions
  • Chambers USA, Healthcare, 2021-2027
  • Best Lawyers in America, Healthcare Law, 2019-2026
  • Thomson Reuters, Stand-Out Lawyer – independently rated lawyers, 2021-2025
  • JD Supra, Readers’ Choice Awards, Top Author in Life Sciences (2024), Top Author in Healthcare, 2025
  • Lexology, Legal Influencer for Healthcare and Life Sciences – US, Q1 2023 and Q4 2024

See more

Capabilities and industries
Regional markets
Community
  • McDermott, Healthcare Regulatory & Compliance Practice Group, practice area leader
  • McDermott, Gender Diversity Committee, member and mentor
  • American Health Law Association, Medicare and Medicaid Institute, chair; Planning Committee for Institute on Medicare and Medicaid Payment Issues, member
  • Representing Hospitals and Health Systems, American Health Law Association, contributing editor
Credentials
Education
  • University of Chicago Law School, JD, with honors
  • University of North Carolina at Chapel Hill, MSPH, Delta Omega honor
  • Duke University, BA, cum laude, with distinction
Admissions
  • California
  • District of Columbia
Languages
  • English